Department of Hepato-Pancreato-Biliary and Liver Transplant Surgery, Queen Elizabeth University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK.
Department of Hepato-Pancreato-Biliary and Liver Transplantation, Henri Mondor University Hospital, 94010, Créteil, France.
Langenbecks Arch Surg. 2019 May;404(3):285-292. doi: 10.1007/s00423-019-01771-4. Epub 2019 Mar 7.
BACKGROUND-OBJECTIVE: The outcomes of split liver transplantation between recipients of deceased donor split liver transplant (SLT) or live donor liver transplants (LDLT) have never been compared in meta-analysis. It is important to understand graft and recipient survival between recipients of these grafts.
Databases were searched for relevant articles over the previous 20 years (MEDLINE, Embase, Cochrane Library and Google Scholar). Meta-analyses were performed using both fixed- and random-effects models. Patient survival and graft survival were obtained using the inverse variance hazard ratio method.
There were differences in the characteristics of the donors and recipients. Donors of the SLT were younger compared to LDLT cohort [mean difference (MD) = - 11.12 years (- 15.41 to - 6.84), p < 0.001] whilst recipients of LDLT were younger [MD = - 2.06 years (- 1.12 to - 3.01), p < 0.001]. Significantly fewer men received grafts after SLT, 45%, compared to those receiving LDLT, 55%, [OR = 0.66 (0.55 to 0.80), p < 0.001]. There were no significant differences detected in postoperative complications, graft and patient 1-, 3- and 5-year survival between the SLT and LDLT cohorts.
There is no apparent difference in overall survival, graft survival or complications between recipients of SLT or LDLT. However, characteristics of the donor and recipients differed suggesting the need for adequate risk-adjusted assessment of outcomes.
在荟萃分析中,从未比较过接受已故供体劈离式肝移植(SLT)或活体供体肝移植(LDLT)的受者之间的肝移植结果。了解这些供体的移植物和受者的存活率非常重要。
在过去 20 年中,检索了数据库中相关的文章(MEDLINE、Embase、Cochrane 图书馆和 Google Scholar)。使用固定效应和随机效应模型进行了荟萃分析。使用倒数方差风险比法获得患者生存率和移植物生存率。
供体和受者的特征存在差异。SLT 供体的年龄较 LDLT 队列年轻[平均差异(MD)= -11.12 岁(-15.41 至 -6.84),p < 0.001],而 LDLT 受者的年龄则较年轻[MD = -2.06 岁(-1.12 至 -3.01),p < 0.001]。接受 SLT 后,接受移植物的男性明显少于 LDLT 组,为 45%,而接受 LDLT 的男性为 55%[比值比(OR)= 0.66(0.55 至 0.80),p < 0.001]。在术后并发症、移植物和患者 1、3 和 5 年生存率方面,SLT 和 LDLT 队列之间未发现明显差异。
在接受 SLT 或 LDLT 的患者中,总体生存率、移植物生存率或并发症之间没有明显差异。然而,供体和受者的特征不同,表明需要对结果进行充分的风险调整评估。